Drug · DIN 02566923
XBRYK
SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 30, 2026.
- Drug Identification Number (DIN)
- 02566923
- Company (DIN owner)
- Samsung Bioepis Co., LtdIncheon, Incheon, Korea, Republic Of
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Denosumab M05BX04
- Class
- Human
- Record last updated
- July 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DENOSUMAB | 120 MG | 1.7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 30, 2026: NOC 37229New Drug Submission (NDS)